Originally Posted: October 29, 2019
A 2019 research publication from Robert Harrod (Department of Biological Sciences) was cited on Businesswire. This work was the product of a collaboration with investigators at the UT-Houston M.D. Anderson Cancer Center. The paper was published in the Journal of Antivirals & Antiretrovirals:
Hutchison T., Yapindi L., Malu A., Newman R.A., Sastry K.J., & Harrod R (2019). The botanical glycoside oleandrin inhibits human T-cell leukemia virus type-1 infectivity and Env-dependent virological synapse formation. J. Antivirals & Antiretrovirals 11(2), 1-11.